rxstat › Shortages › Famotidine

Famotidine shortage status

Widespread shortage Tier 3: critical

Source: Health Canada shortage reports · Updated Jul 9, 2026

Famotidine is in a widespread shortage in Canada. 3 of 13 reported products are affected, and Health Canada has designated this a Tier 3 (most serious) shortage. The latest manufacturer estimate for full recovery is Sep 18, 2026.
Products affected
3 of 13
In shortage since
Mar 10, 2017
Est. full return
Sep 18, 2026
Reports on file
48
Talk to your pharmacist. Pharmacists can often substitute another manufacturer's version, a different strength, or (in most provinces) adapt or renew a prescription on the spot. Your free provincial health line is 811.

Reports by product

Active shortage
FAMOTIDINE OMEGA -(WITH PRESERVATIVE,BENZYL ALCOHOL)
10MG · SOLUTION · OMEGA LABORATORIES LIMITED
DIN 02247745 · since Jul 6, 2026, est. end Sep 18, 2026 · Demand increase for the drug.
Active shortage
FAMOTIDINE OMEGA -(WITHOUT PRESERVATIVE)
10MG · SOLUTION · OMEGA LABORATORIES LIMITED
DIN 02247735 · since Mar 2, 2026, est. end Aug 31, 2026 · Disruption of the manufacture of the drug.
Active shortage
APO-FAMOTIDINE
10MG · TABLET · APOTEX INC
DIN 02231119 · since Mar 10, 2017, no end estimate · Disruption of the manufacture of the drug.
Anticipated
FAMOTIDINE
20MG · TABLET · SANIS HEALTH INC
DIN 02351102 · Disruption of the manufacture of the drug.
Resolved
TEVA-FAMOTIDINE
20MG · TABLET · TEVA CANADA LIMITED
DIN 02022133 · ended Feb 11, 2026 · Disruption of the manufacture of the drug.
Resolved
TEVA-FAMOTIDINE
40MG · TABLET · TEVA CANADA LIMITED
DIN 02022141 · ended Feb 11, 2026 · Disruption of the manufacture of the drug.
Resolved
FAMOTIDINE OMEGA -(WITH PRESERVATIVE,BENZYL ALCOHOL)
10MG · SOLUTION · OMEGA LABORATORIES LIMITED
DIN 02247745 · ended Oct 15, 2025 · Disruption of the manufacture of the drug.
Resolved
TEVA-FAMOTIDINE
20MG · TABLET · TEVA CANADA LIMITED
DIN 02022133 · ended Jul 17, 2025 · Disruption of the manufacture of the drug.
Resolved
FAMOTIDINE OMEGA -(WITHOUT PRESERVATIVE)
10MG · SOLUTION · OMEGA LABORATORIES LIMITED
DIN 02247735 · ended Jun 6, 2025 · Demand increase for the drug.
Discontinued
TEVA-FAMOTIDINE
40MG · TABLET · TEVA CANADA LIMITED
DIN 02022141
Resolved
FAMOTIDINE OMEGA -(WITHOUT PRESERVATIVE)
10MG · SOLUTION · OMEGA LABORATORIES LIMITED
DIN 02247735 · ended Aug 30, 2024 · Demand increase for the drug.
Resolved
FAMOTIDINE OMEGA -(WITH PRESERVATIVE,BENZYL ALCOHOL)
10MG · SOLUTION · OMEGA LABORATORIES LIMITED
DIN 02247745 · ended Apr 22, 2024 · Disruption of the manufacture of the drug.

Showing 12 of 48 reports. All reports are on file with Health Canada.

What's happening

Famotidine is currently affected by 3 active shortage reports filed with Health Canada by OMEGA LABORATORIES LIMITED, APOTEX INC.

The reported causes are: demand increase for the drug; disruption of the manufacture of the drug. Manufacturers must report shortages, but end-date estimates are their own projections and often move.

Health Canada has flagged this as a Tier 3 shortage, its most serious category, meaning the shortage has the greatest potential impact on the health system and alternatives are limited.

If your usual product is affected, a pharmacist is the fastest route to a solution: they can dispense an unaffected manufacturer's equivalent when one exists, and in most provinces can adapt doses or substitute a therapeutic alternative without a new appointment.

Famotidine is classified under “DRUGS FOR PEPTIC ULCER AND GASTROESOPHAGEAL REFLUX DISEASE (GERD)” (ATC A02BA).

Recent changes

Common questions

When will Famotidine be back in stock in Canada?

The latest manufacturer estimate is Sep 18, 2026. Estimates are self-reported and often slip; this page updates automatically when they change.

Why is Famotidine in shortage?

See the reports above; manufacturers must state a reason (most commonly manufacturing disruption or a surge in demand) when filing with Health Canada.

What can my pharmacist do about it?

Often quite a lot: substitute an equivalent product from an unaffected manufacturer, adjust quantities, or in most provinces adapt or renew prescriptions on the spot. Call your pharmacy before visiting, and call 811 for free health advice.

Related drugs (drugs for peptic ulcer and gastroesophageal reflux disease (gerd))

Partial shortageCimetidine3 of 9 reported products affectedPartial shortageEsomeprazole12 of 26 reported products affected · est. return Oct 10, 2027Partial shortageLansoprazole6 of 22 reported products affected · est. return Dec 29, 2026Partial shortageOmeprazole10 of 22 reported products affected · est. return Aug 14, 2026Partial shortagePantoprazole7 of 35 reported products affected · est. return Sep 29, 2026Partial shortageRabeprazole4 of 21 reported products affected · est. return Jun 30, 2026

All drugs for peptic ulcer and gastroesophageal reflux disease (gerd) shortage statuses →

Guides: what to do when your medication is in shortage · how to read shortage reports

Data reflects reports manufacturers are legally required to file with Health Canada, republished with per-drug aggregation by rxstat. Estimated end dates are supplied by manufacturers and frequently change. This page describes drug supply only and is not medical advice; never stop or switch a medication without speaking to your pharmacist or prescriber.